Pluri (PLUR) Metrics: History & Chart

Pluri Inc.(PLUR)

Biotechnology · Haifa, HA

$0.98-0.05 (-5.14%)

Delayed quote: Oct 6, 2026, 1:15 PM EDT

About Pluri Inc.

Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders. The company's therapeutic pipeline centers on placental expanded (PLX) cell technology. A key candidate, PLX-PAD, is in advanced clinical development, with ongoing Phase III trials for muscle recovery after hip fracture surgery, Phase II studies for acute respiratory distress syndrome associated with COVID-19, and Phase I/II trials for steroid-refractory Graft-versus-Host Disease. Additionally, Pluri is advancing PLX-R18, a treatment designed to aid in incomplete hematopoietic recovery following hematopoietic cell transplantation and to address acute radiation syndrome. The company rebranded to Pluri Inc. in July 2022, having previously operated as Pluristem Therapeutics Inc.

Haifa, HA

92 employees

www.pluri-biotech.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Yaacov Yanay

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+7.20%
30D Total Return	-23.54%
YTD Total Return	-65.22%
1Y Total Return	-77.44%
3Y Total Return	-75.93%
5Y Total Return	-94.86%
10Y Total Return	-99.17%
15Y Total Return	-99.41%
20Y Total Return	-99.68%

2026	-65.22%
2025	-30.14%
2024	-7.76%
2023	-38.30%
2022	-35.62%
2021	-79.35%
2020

CAGR TTM	-77.28%
CAGR 3Y	-37.79%
CAGR 5Y	-44.78%
CAGR 10Y	-38.09%
CAGR 15Y	-28.95%
CAGR 20Y	-24.91%

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

PLUR Valuation Metrics

PLUR Stock Price Metrics

PLUR Dividend Metrics

PLUR Growth Rate Metrics

PLUR Discounted Cash Flow Metrics

PLUR Returns By Period

PLUR Yearly Returns

PLUR Average Annual Returns By Period (CAGR)

PLUR Revenue Metrics

PLUR PE Ratio Metrics

PLUR PS Ratio Metrics

PLUR PB Ratio Metrics

PLUR Price to Free Cash Flow Ratio Metrics

PLUR Debt to Equity Ratio Metrics

PLUR PEG Ratio Metrics

PLUR FCF Yield

PLUR Earnings Yield

PLUR EBITDA Yield

PLUR OCF Yield

PLUR EV/EBIT Ratio Metrics

PLUR EV/EBITDA Ratio Metrics

PLUR EV/Assets Ratio Metrics

PLUR EV/Sales Ratio Metrics

PLUR Current Ratio Metrics

PLUR Quick Ratio Metrics

PLUR ROIC Metrics

PLUR Return on Assets Metrics

PLUR Return on Equity Metrics

PLUR Net Profit Margin Metrics

PLUR Gross Profit Margin Metrics

PLUR Tax Rate Metrics

PS Ratio	11.08
PS Ratio Avg TTM	20.97
PS Ratio Avg 3Y	50.00
Current VS TTM Avg	-47.15%
Current VS 3Y Avg	-77.84%
Current VS 5Y Avg	-85.49%

PB Ratio	311.52
PB Ratio Avg TTM	86.41
PB Ratio Avg 3Y	1.42
Current VS TTM Avg	+260.50%
Current VS 3Y Avg	+21850.07%
Current VS 5Y Avg	+14214.36%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	(1.52)
Debt/Equity Ratio Avg TTM	(2.93)
Debt/Equity Ratio Avg 3Y	(1.70)
Current VS TTM Avg	+48.23%
Current VS 3Y Avg	+10.62%
Current VS 5Y Avg	-157.44%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	985.33
Ev/Ebitda Ratio Avg TTM	1080.85
Ev/Ebitda Ratio Avg 3Y	1080.85
Current VS TTM Avg	-8.84%
Current VS 3Y Avg	-8.84%
Current VS 5Y Avg	-8.84%

Ev/Assets Ratio	1.71
Ev/Assets Ratio Avg TTM	1.94
Ev/Assets Ratio Avg 3Y	1.55
Current VS TTM Avg	-11.71%
Current VS 3Y Avg	+10.22%
Current VS 5Y Avg	+35.74%

Ev/Sales Ratio	41.97
Ev/Sales Ratio Avg TTM	47.48
Ev/Sales Ratio Avg 3Y	96.27
Current VS TTM Avg	-11.60%
Current VS 3Y Avg	-56.41%
Current VS 5Y Avg	-68.32%

Current Ratio	0.27
Current Ratio Avg TTM	0.45
Current Ratio Avg 3Y	4.13
Current VS TTM Avg	-40.18%
Current VS 3Y Avg	-93.54%
Current VS 5Y Avg	-95.19%

Quick Ratio	0.27
Quick Ratio Avg TTM	0.45
Quick Ratio Avg 3Y	4.13
Current VS TTM Avg	-40.18%
Current VS 3Y Avg	-93.54%
Current VS 5Y Avg	-95.19%

ROIC	(127.37%)
ROIC Avg 3Y	(71.50%)
ROIC Avg 5Y	(67.55%)
Current VS 3Y Avg	-78.15%
Current VS 5Y Avg	-88.56%
Current VS 10Y Avg	-53.26%

ROA	(98.26%)
ROA Avg TTM	(21.14%)
ROA Avg 3Y	(16.39%)
Current VS TTM Avg	-364.71%
Current VS 3Y Avg	-499.64%
Current VS 5Y Avg	-587.78%

ROE	N/A
ROE Avg TTM	(273.26%)
ROE Avg 3Y	(127.46%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(2406.00%)
Net Profit Margin Avg TTM	(2503.18%)
Net Profit Margin Avg 3Y	(3881.36%)
Current VS TTM Avg	+3.88%
Current VS 3Y Avg	+38.01%
Current VS 5Y Avg	+31.72%

Gross Profit Margin	44.59%
Gross Pft Margin Avg TTM	38.98%
Gross Pft Margin Avg 3Y	65.24%
Current VS TTM Avg	+14.39%
Current VS 3Y Avg	-31.65%
Current VS 5Y Avg	-14.32%

Tax Rate	0.89%
Tax Rate Avg 3Y	6.42%
Tax Rate Avg 5Y	5.47%
Current VS 3Y Avg	-86.11%
Current VS 5Y Avg	-83.70%
Current VS 10Y Avg	+117.86%